Headband tracks sleep to warn of seizure danger

NCT ID NCT06545643

Recruiting now Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses a comfortable headband (Dreem) to monitor brain activity and sleep patterns in 35 adults with hard-to-control epilepsy. Participants wear the device at home for several nights to see how poor sleep affects their seizures. The goal is to learn which patients are most at risk after bad sleep, so doctors can tailor treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dreem headband (wearable EEG device)
What this could lead to: If successful, this could help doctors identify which people with epilepsy are most sensitive to poor sleep, leading to personalized treatment plans.
What could go wrong: This is a small, early observational study (35 people) that only measures sleep and seizures—it does not test a treatment. Results may not apply to everyone with epilepsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY INTRACTABLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY INTRACTABLE

Contacts and locations

Locations

Duke University Health System
RECRUITING

Durham, North Carolina, 27710, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.